Caribou Biosciences Inc. is a leading biotechnology company that specializes in developing CRISPR-Cas9 gene editing technology. With a strong focus on precision medicine, Caribou aims to revolutionize the treatment of genetic diseases and enhance agricultural and industrial applications. Their innovative approach and dedication to scientific excellence make them a key player in the rapidly evolving field of gene editing.
